The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Canespor 10 mg/g cream

Bayer LimitedPA1410/083/001

Main Information

Trade NameCanespor 10 mg/g cream
Active SubstancesBifonazole
Dosage FormCream
Licence HolderBayer Limited
Licence NumberPA1410/083/001

Group Information

ATC CodeD01AC Imidazole and triazole derivatives
D01AC10 bifonazole


License statusAuthorised
Licence Issued09/03/2018
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back